Elanco Animal Health, Inc. (ELAN)
24.50
+0.82
(+3.44%)
USD |
NYSE |
Jun 09, 16:00
24.52
+0.02
(+0.10%)
After-Hours: 20:00
Elanco Animal Health Research and Development Expense (Quarterly) : 97.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zoetis, Inc. | 180.00M |
| Eli Lilly & Co. | 3.51B |
| Phibro Animal Health Corp. | -- |
| Royalty Pharma Plc | 39.79M |
| ANI Pharmaceuticals, Inc. | 10.60M |